Related Experiment Video
Updated: Jan 5, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Pneumocystis pneumonia: still a serious disease in children
Magdalena Zakrzewska1, Renata Roszkowska2, Mateusz Zakrzewski1
1Department of Developmental Age Medicine and Pediatric Nursing, Medical University of Białystok, Białystok, Poland.
Insights
Pneumocystis pneumonia is a serious opportunistic infection in children with weakened immune systems. Early diagnosis and treatment with trimethoprim-sulfamethoxazole are crucial for reducing mortality.
Area of Science:
- Pediatric infectious diseases
- Immunology
- Pulmonology
Background:
- Pneumocystis pneumonia (PCP) is a common opportunistic infection in immunocompromised children, particularly those with HIV.
- Primary infection in immunocompetent individuals may be asymptomatic, but severe disease presents with respiratory symptoms.
Purpose of the Study:
- To review the epidemiology, diagnosis, and treatment of Pneumocystis pneumonia in pediatric patients.
- To highlight the importance of early detection and intervention.
Main Methods:
- Review of current literature and international recommendations.
- Discussion of diagnostic methods including histochemical staining and polymerase chain reaction (PCR).
- Evaluation of therapeutic options, focusing on trimethoprim-sulfamethoxazole.
Main Results:
- Pneumocystis pneumonia presents with symptoms like fever, cough, and respiratory distress.
- Diagnosis can be confirmed through biological specimen analysis.
- Intravenous trimethoprim-sulfamethoxazole is the recommended treatment.
Conclusions:
- Prompt diagnosis and effective treatment are vital for improving outcomes in pediatric Pneumocystis pneumonia.
- Understanding the epidemiology and available therapies is essential for clinicians managing these cases.
Abstract:
Pneumocystis carinii pneumonia is a common opportunistic respiratory infection among children with human immunodeficiency virus and a weakened immune system. The primary infection in immunocompetent patients may be asymptomatic, whereas fever, shortness of breath, night sweats, nonproductive (dry) cough, pneumonia, progressive respiratory distress and apnea are cardinal symptoms of full-blown pneumocystis pneumonia. The diagnosis can be confirmed by histochemical staining of biological specimens or, recently, by polymerase chain reaction. International recommendations indicate that the drug of choice is the intravenously administered trimethoprim-sulfamethoxazole combination. Early diagnosis and appropriate treatment reduce the mortality of the disease. This article briefly highlights the epidemiology of Pneumocystis pneumonia, its diagnosis and therapeutic options in the pediatric population.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumothorax-I
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.

